These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subclinical atherosclerosis in primary Sjögren's syndrome: comparable risk with diabetes mellitus. Zhang Y; Luo Q; Lu K; You M; Wang H Clin Rheumatol; 2023 Jun; 42(6):1607-1614. PubMed ID: 36813944 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of subclinical atherosclerosis by ultrasound radiofrequency data technology in patients with primary Sjögren's syndrome. Ozisler C; Kaplanoglu H Clin Rheumatol; 2019 Mar; 38(3):709-717. PubMed ID: 30334118 [TBL] [Abstract][Full Text] [Related]
4. Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren's syndrome: a potential contribution of sleep impairment. Karageorgas T; Ioakeimidis D; Mavragani CP Clin Exp Rheumatol; 2018; 36 Suppl 112(3):68-72. PubMed ID: 29148412 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective? Cinoku I; Mavragani CP; Tellis CC; Nezos A; Tselepis AD; Moutsopoulos HM Clin Exp Rheumatol; 2018; 36 Suppl 112(3):61-67. PubMed ID: 30156537 [TBL] [Abstract][Full Text] [Related]
6. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study. Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929 [TBL] [Abstract][Full Text] [Related]
8. Risk of subclinical atherosclerosis in primary Sjogren's syndrome: A systematic review and meta-analysis. Karakasis P; Patoulias D; Pamporis K; Stachteas P; Lefkou E; Bougioukas KI; Dimitroulas T; Fragakis N Eur J Intern Med; 2024 Apr; 122():93-101. PubMed ID: 37977997 [TBL] [Abstract][Full Text] [Related]
9. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. Abbara S; Seror R; Henry J; Chretien P; Gleizes A; Hacein-Bey-Abina S; Mariette X; Nocturne G RMD Open; 2019; 5(2):e001033. PubMed ID: 31673417 [TBL] [Abstract][Full Text] [Related]
10. Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren's syndrome. Balarini GM; Zandonade E; Tanure L; Ferreira GA; Sardenberg WM; Serrano ÉV; Dias CC; Navarro TP; Nordal HH; Mydel PM; Brun JG; Brokstad KA; Gerdts E; Jonsson R; Valim V Clin Exp Rheumatol; 2016; 34(6):1006-1012. PubMed ID: 27749218 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of abnormal ankle brachial index in patients with primary Sjogren's syndrome. Rachapalli SM; Kiely PD; Bourke BE Clin Rheumatol; 2009 May; 28(5):587-90. PubMed ID: 19205787 [TBL] [Abstract][Full Text] [Related]
12. New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome: a pilot study. Atzeni F; Sarzi-Puttini P; Signorello MC; Gianturco L; Stella D; Boccassini L; Ricci C; Bodini BD; Batticciotto A; De Gennaro-Colonna V; Drago L; Turiel M Clin Exp Rheumatol; 2014; 32(3):361-8. PubMed ID: 24565029 [TBL] [Abstract][Full Text] [Related]
13. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome. Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E Front Immunol; 2019; 10():1153. PubMed ID: 31191532 [TBL] [Abstract][Full Text] [Related]
14. Association between primary Sjogren's syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis. Yong WC; Sanguankeo A; Upala S Clin Rheumatol; 2019 Feb; 38(2):447-455. PubMed ID: 30178172 [TBL] [Abstract][Full Text] [Related]
15. Renal tubular acidosis and associated factors in patients with primary Sjögren's syndrome: a registry-based study. Zhang Y; Qiao L; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Li M; Zhao Y; Zeng X Clin Rheumatol; 2023 Feb; 42(2):431-441. PubMed ID: 36383239 [TBL] [Abstract][Full Text] [Related]
17. Levels of Vitamin D, Disease Activity and Subclinical Atherosclerosis in Post-menopausal Women with Sjögren's Syndrome: Does a Link Exist? Zardi EM; Basta F; Afeltra A In Vivo; 2016 09-10; 30(5):721-5. PubMed ID: 27566098 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome. Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756 [TBL] [Abstract][Full Text] [Related]
19. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428 [TBL] [Abstract][Full Text] [Related]
20. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Kvarnström M; Ottosson V; Nordmark B; Wahren-Herlenius M Scand J Rheumatol; 2015; 44(2):135-42. PubMed ID: 25222653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]